Production (Stage)
MIRA Pharmaceuticals, Inc.
MIRA
$1.40
$0.032.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.84% | 58.54% | 43.03% | -33.58% | -28.10% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.89% | -90.53% | -81.15% | -18.29% | 234.58% |
| Change in Net Operating Assets | -529.23% | 116.61% | -69.10% | 152.03% | 44.45% |
| Cash from Operations | -55.31% | -74.40% | -4.59% | -30.74% | 2.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 101.44% | -- | 118.26% | -- |
| Issuance of Common Stock | -- | -- | -65.44% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 103.29% | -91.52% | -- |
| Cash from Financing | 113.99% | 313.87% | -58.41% | -76.76% | -103.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.47% | -3.62% | -77.40% | -3,099.57% | -207.18% |